Clinical trial

5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors

NCT07589101

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhaseNA

Study timeline

Study start (estimated)2026-06-01Date precision: day

Registry last updated2026-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Breast Cancerunresolved

Interventions

18F-FDGDRUG

68Ga-MYDRUG

Sponsors & collaborators

Peking University Cancer Hospital & Institutelead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07589101 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.